Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Background: In many risk-stratification systems, the decision to biopsy thyroid nodules is
determined by their sonographic features and size. Nevertheless, even low-suspicion …

Despite considerable advances in the evolution of anticancer therapies, metastasis still
remains the main cause of cancer mortality. Therefore, current strategies for cancer cure …

Background Lateral neck lymph node (LN) metastases (N1b) have been identified as
independent risk factors of recurrence in patients with papillary thyroid carcinoma (PTC) …

Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated
thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Ambient ionization mass spectrometry has been widely applied to image lipids and
metabolites in primary cancer tissues with the purpose of detecting and understanding …

Objective Papillary thyroid microcarcinoma (PTMC) comprises more than 50% of all newly
detected cases of papillary thyroid carcinoma (PTC). High‐volume lymph node metastasis …